Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03345082
Brief Title: A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

First Submitted : November 14, 2017
First Submitted that Met QC Criteria : November 14, 2017
First Posted : November 17, 2017

Certification/Extension First Submitted : January 8, 2021
Certification/Extension First Submitted that Met QC Criteria : January 8, 2021
Certification/Extension First Posted : January 12, 2021

Last Update Submitted that Met QC Criteria : January 8, 2021
Last Update Posted : January 12, 2021